Health Economics and Investment in Women's Health Systems

The chronic underinvestment in women's health systems represents one of the most economically consequential failures of global health policy, generating preventable morbidity, mortality, and productivity losses that compound across generations. This chapter examines the health economics of investing in women's health systems through a comprehensive integrative review. Topics include the economics of investing in women and health; maternal mortality in LMICs; scaling health interventions; SRHR decision-making; menstrual health and endometriosis costs; NIH gender funding disparities; endometriosis underfunding; clinical trial female enrolment; gender and NCD economic impacts; gendered NCD political mapping; health workforce gender pay gap; gender equality in health leadership; COVID-19 gender equality impacts; hostile abortion legislation; and abortion policy socioeconomic consequences. A systems pathway model, funding gap lollipop profile, and cumulative investment return projection are developed alongside policy implications.

Hali tarjima qilinmagan